These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38316739)

  • 21. Evaluation of in-sewer transformation of selected illicit drugs and pharmaceutical biomarkers.
    Gao J; Banks A; Li J; Jiang G; Lai FY; Mueller JF; Thai PK
    Sci Total Environ; 2017 Dec; 609():1172-1181. PubMed ID: 28787791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulated 2017 nationwide sampling at 13,940 major U.S. sewage treatment plants to assess seasonal population bias in wastewater-based epidemiology.
    Hart OE; Halden RU
    Sci Total Environ; 2020 Jul; 727():138406. PubMed ID: 32334208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can wastewater-based epidemiology be used to evaluate the health impact of temperature? - An exploratory study in an Australian population.
    Phung D; Mueller J; Lai FY; O'Brien J; Dang N; Morawska L; Thai PK
    Environ Res; 2017 Jul; 156():113-119. PubMed ID: 28342346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A global systematic review and meta-analysis on illicit drug consumption rate through wastewater-based epidemiology.
    Zarei S; Salimi Y; Repo E; Daglioglu N; Safaei Z; Güzel E; Asadi A
    Environ Sci Pollut Res Int; 2020 Oct; 27(29):36037-36051. PubMed ID: 32594443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.
    Baz-Lomba JA; Salvatore S; Gracia-Lor E; Bade R; Castiglioni S; Castrignanò E; Causanilles A; Hernandez F; Kasprzyk-Hordern B; Kinyua J; McCall AK; van Nuijs A; Ort C; Plósz BG; Ramin P; Reid M; Rousis NI; Ryu Y; de Voogt P; Bramness J; Thomas K
    BMC Public Health; 2016 Oct; 16(1):1035. PubMed ID: 27716139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal variations and trends in loads of commonly used pharmaceuticals to large wastewater treatment plants in Sweden, a case study (Ryaverket).
    Paxéus N; Bester K; El-taliawy H
    Water Sci Technol; 2016; 73(12):3049-56. PubMed ID: 27332852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do food and stress biomarkers work for wastewater-based epidemiology? A critical evaluation.
    Choi PM; Bowes DA; O'Brien JW; Li J; Halden RU; Jiang G; Thomas KV; Mueller JF
    Sci Total Environ; 2020 Sep; 736():139654. PubMed ID: 32497888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of spatial and temporal changes in illicit drug use in the Taipei metropolitan area via wastewater-based epidemiology.
    Lin HH; Wang YH; Liu JIWW; Hsieh MC; Huang SJ; Lien E; Huang LW; Lin AY
    Sci Total Environ; 2024 Jul; 934():173313. PubMed ID: 38761952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-sewer stability of 31 human health biomarkers and suitability for wastewater-based epidemiology.
    Li J; Choi PM; Gao J; Ren J; O'Brien JW; Thomas KV; Mueller JF; Thai PK; Jiang G
    Water Res; 2024 Feb; 249():120978. PubMed ID: 38071905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of in-sewer transformation on 43 pharmaceuticals in a pressurized sewer under anaerobic conditions.
    Jelic A; Rodriguez-Mozaz S; Barceló D; Gutierrez O
    Water Res; 2015 Jan; 68():98-108. PubMed ID: 25462720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Illicit Drug Consumption by Wastewater Analysis Using Polar Organic Chemical Integrative Sampler as a Monitoring Tool.
    Hahn RZ; Augusto do Nascimento C; Linden R
    Front Chem; 2021; 9():596875. PubMed ID: 33859973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations for assessing stability of wastewater-based epidemiology biomarkers using biofilm-free and sewer reactor tests.
    Choi PM; Li J; Gao J; O'Brien JW; Thomas KV; Thai PK; Jiang G; Mueller JF
    Sci Total Environ; 2020 Mar; 709():136228. PubMed ID: 31887516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calibration and validation of a microporous polyethylene passive sampler for quantitative estimation of illicit drug and pharmaceutical and personal care product (PPCP) concentrations in wastewater influent.
    McKay S; Tscharke B; Hawker D; Thompson K; O'Brien J; Mueller JF; Kaserzon S
    Sci Total Environ; 2020 Feb; 704():135891. PubMed ID: 31838300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of illicit drug consumption in a population of Hanoi: an estimation using wastewater-based epidemiology.
    Hue TTT; Zheng Q; Anh NTK; Binh VN; Trung NQ; Trang HT; Chinh PQ; Minh LQ; Thai PK
    Sci Total Environ; 2022 Apr; 815():152724. PubMed ID: 34995598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
    Hahn RZ; Bastiani MF; Lizot LLF; Schneider A; da Silva Moreira IC; Meireles YF; Viana MF; do Nascimento CA; Linden R
    Chemosphere; 2022 Sep; 302():134907. PubMed ID: 35561781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
    Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
    Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community infectious disease treatment with antimicrobial agents - A longitudinal one year study of antimicrobials in two cities via wastewater-based epidemiology.
    Sims N; Holton E; Jagadeesan K; Standerwick R; Barden R; Kasprzyk-Hordern B
    J Hazard Mater; 2023 Jul; 454():131461. PubMed ID: 37119569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using wastewater-based epidemiology to estimate consumption of alcohol and nicotine in major cities of China in 2014 and 2016.
    Gao J; Zheng Q; Lai FY; Gartner C; Du P; Ren Y; Li X; Wang D; Mueller JF; Thai PK
    Environ Int; 2020 Mar; 136():105492. PubMed ID: 31999969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new Wastewater-Based Epidemiology workflow to estimate community wide non-communicable disease prevalence using pharmaceutical proxy data.
    Ceolotto N; Dollamore P; Hold A; Balne B; Jagadeesan KK; Standerwick R; Robertson M; Barden R; Kasprzyk-Hordern B
    J Hazard Mater; 2024 Jan; 461():132645. PubMed ID: 37793253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
    Hayden KR; Jones M; Elkin KR; Shreve MJ; Clees WI; Clark S; Mashtare ML; Veith TL; Elliott HA; Watson JE; Silverman J; Richard TL; Read AF; Preisendanz HE
    J Environ Qual; 2022 Sep; 51(5):1066-1082. PubMed ID: 35919971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.